This article is more than 5 years old. Information may no longer be current.

VIDEO: Early initiation of ART has ‘important consequences’ for TB management

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The evidence supporting early initiation of ART regardless of CD4 count has “several important consequences” related to managing tuberculosis in this population, according to Amita Gupta, MD, MHS, of Johns Hopkins University School of Medicine.

Gupta reviews recent investigations that support the role of early ART in TB prevention, including the TEMPRANO trial, the HPTN 052 study and the Strategic Timing of AntiRetroviral Treatment, or START, trial. ART is “a very powerful prevention tool for reducing morbidity and mortality related to TB,” she said.

Research also supports the use of isoniazid preventive therapy in children with HIV, although its use in children aged 1 year or under is not yet fully elucidated.

“We are clearly recommending the ART component for young children, but the question of whether to use [isoniazid] in really young infants is still not entirely clear,” Gupta said.